BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31451744)

  • 21. Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2
    Lazovic B; Nguyen HT; Ansarizadeh M; Wigge L; Kohl F; Li S; Carracedo M; Kettunen J; Krimpenfort L; Elgendy R; Richter K; De Silva L; Bilican B; Singh P; Saxena P; Hong X; Eklund L; Hicks R
    Angiogenesis; 2024 May; ():. PubMed ID: 38771392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects.
    Wouters V; Limaye N; Uebelhoer M; Irrthum A; Boon LM; Mulliken JB; Enjolras O; Baselga E; Berg J; Dompmartin A; Ivarsson SA; Kangesu L; Lacassie Y; Murphy J; Teebi AS; Penington A; Rieu P; Vikkula M
    Eur J Hum Genet; 2010 Apr; 18(4):414-20. PubMed ID: 19888299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variable Somatic TIE2 Mutations in Half of Sporadic Venous Malformations.
    Soblet J; Limaye N; Uebelhoer M; Boon LM; Vikkula M
    Mol Syndromol; 2013 Apr; 4(4):179-83. PubMed ID: 23801934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans.
    Castillo SD; Tzouanacou E; Zaw-Thin M; Berenjeno IM; Parker VE; Chivite I; Milà-Guasch M; Pearce W; Solomon I; Angulo-Urarte A; Figueiredo AM; Dewhurst RE; Knox RG; Clark GR; Scudamore CL; Badar A; Kalber TL; Foster J; Stuckey DJ; David AL; Phillips WA; Lythgoe MF; Wilson V; Semple RK; Sebire NJ; Kinsler VA; Graupera M; Vanhaesebroeck B
    Sci Transl Med; 2016 Mar; 8(332):332ra43. PubMed ID: 27030595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association study between of Tie2/angiopoietin-2 and VEGF/KDR pathway gene polymorphisms and vascular malformations.
    Zheng Q; Du J; Zhang Z; Xu J; Fu L; Cao Y; Huang X; Guo L
    Gene; 2013 Jul; 523(2):195-8. PubMed ID: 23566851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Patient-Derived Xenograft Model for Venous Malformation.
    Schrenk S; Goines J; Boscolo E
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32597867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disorganized vascular structures in sporadic venous malformations: a possible correlation with balancing effect between Tie2 and TGF-β.
    Chen G; Ren JG; Zhang W; Sun YF; Wang FQ; Li RF; Zhang J; Zhao YF
    Sci Rep; 2014 Jun; 4():5457. PubMed ID: 24966004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations.
    Soblet J; Kangas J; Nätynki M; Mendola A; Helaers R; Uebelhoer M; Kaakinen M; Cordisco M; Dompmartin A; Enjolras O; Holden S; Irvine AD; Kangesu L; Léauté-Labrèze C; Lanoel A; Lokmic Z; Maas S; McAleer MA; Penington A; Rieu P; Syed S; van der Vleuten C; Watson R; Fishman SJ; Mulliken JB; Eklund L; Limaye N; Boon LM; Vikkula M
    J Invest Dermatol; 2017 Jan; 137(1):207-216. PubMed ID: 27519652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-35 Inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis.
    Jiang S; Li Y; Lin T; Yuan L; Li Y; Wu S; Xia L; Shen H; Lu J
    Cell Physiol Biochem; 2016; 40(5):1105-1116. PubMed ID: 27960151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatic mutations in exon 17 of the TEK gene in vascular tumors and vascular malformations.
    Ye C; Pan L; Huang Y; Ye R; Han A; Li S; Li X; Wang S
    J Vasc Surg; 2011 Dec; 54(6):1760-8. PubMed ID: 21962923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Molecular Therapies for Venous Malformations.
    Kangas J; Nätynki M; Eklund L
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():6-19. PubMed ID: 29668117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of angiogenesis and survival of endothelial cells by human monoclonal Tie2 receptor antibody.
    Hwang B; Lee SH; Kim JS; Moon JH; Jeung IC; Lee NG; Park J; Hong HJ; Cho YL; Jung H; Park YJ; Lee SJ; Lee HG; Kim WK; Han BS; Bae KH; Chung SJ; Kwon YG; Lee SC; Kim SJ; Min JK
    Biomaterials; 2015 May; 51():119-128. PubMed ID: 25771003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells.
    Audero E; Cascone I; Maniero F; Napione L; Arese M; Lanfrancone L; Bussolino F
    J Biol Chem; 2004 Mar; 279(13):13224-33. PubMed ID: 14665640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A peptide from the extracellular region of the synaptic protein α Neurexin stimulates angiogenesis and the vascular specific tyrosine kinase Tie2.
    Graziano S; Marchiò S; Bussolino F; Arese M
    Biochem Biophys Res Commun; 2013 Mar; 432(4):574-9. PubMed ID: 23485462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.
    Singh H; Milner CS; Aguilar Hernandez MM; Patel N; Brindle NP
    Cell Signal; 2009 Aug; 21(8):1346-50. PubMed ID: 19376222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of UDP-glucose ceramide glucosyltransferase in venous malformation.
    Chen S; Wang Y; Kong L; Ji Y; Cui J; Shen W
    Front Cell Dev Biol; 2023; 11():1178045. PubMed ID: 37274734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the Ang2-Tie2 Axis in Vascular Damage Driven by High Glucose or Nucleoside Diphosphate Kinase B Deficiency.
    Chatterjee A; Eshwaran R; Huang H; Zhao D; Schmidt M; Wieland T; Feng Y
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of an Orthogonal Tie2 Ligand Resistant to Inhibition by Ang2.
    Issa E; Moss AJ; Fischer M; Kang M; Ahmed S; Farah H; Bate N; Giakomidi D; Brindle NP
    Mol Pharm; 2018 Sep; 15(9):3962-3968. PubMed ID: 30036484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial cells induce degradation of ECM through enhanced secretion of MMP14 carried on extracellular vesicles in venous malformation.
    Chen GH; Yang JG; Xia HF; Zhang LZ; Chen YH; Wang KM; Duan X; Wu LZ; Zhao YF; Chen G
    Cell Tissue Res; 2022 Sep; 389(3):517-530. PubMed ID: 35786766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy.
    Shlamkovich T; Aharon L; Barton WA; Papo N
    Oncotarget; 2017 May; 8(20):33571-33585. PubMed ID: 28422724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.